1. Bylund, D.B., Eikenberg, D.C., Hieble, J.P., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., Molinoff, P.B., Ruffolo, R.R., Jr., and Trendelenburg, U., (1994): IV. International union of pharmacology nomenclature of adrenoceptors, Pharmacol. Rev., 46, 121–136.
2. Hieble, J.P., Bylund, D.B., Clarke, D.E., Eikenburg, D.C., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., and Ruffolo, R.R., (1995): International union of pharmacology X. recommendation for nomenclature of a1-adrenoreceptors: consensus update, Pharmacol. Rev., 47, 267–270.
3. Muramatsu, I., Ohmura, T., Kigoshi, S., Hashimoto, S., and Oshita, M., (1990): Pharmacological subclassification of a1-adrenoceptors in vascular smooth muscle, Br. J. Pharmacol. 99, 197–201.
4. Forray, C., Bard, J.A., Wetzel, J.M., Chiu, G., Shapiro, E., Tang, R., Lepor, H., Hartig, P.R., Weinshank, R.L., Branchek, T.A., and Gluchowski, C., (1994): The a1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human a1C subtype, Mol. Pharmacol., 45, 703–708
5. Kuo, G.H., Prouty, C., Murray, W.V., Pulito, V., Jolliffe, L., Cheung, P., Varga, S. 14, Evangelisto, M., and Shaw, C., (2000): Design, synthesis and biological evaluation of pyridine-phenylpiperazines: a novel series of potent and selective a1a-adrenergic receptor antagonist, Bioorg. & Med. Chem., 2263-2275.